Recent Advances of DprE1 Inhibitors against <i>Mycobacterium tuberculosis</i>: Computational Analysis of Physicochemical and ADMET Properties-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties

Published:2022-11-03 Issue:45 Volume:7 Page:40659-40681
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Amado Patrícia S. M.¹²³^ORCID,Woodley Christopher³,Cristiano Maria L. S.¹²^ORCID,O’Neill Paul M.³^ORCID

Affiliation:

1. Center of Marine Sciences - CCMAR, University of Algarve, P-8005-039 Faro, Portugal

2. Department of Chemistry and Pharmacy, FCT, University of Algarve, P-8005-039 Faro, Portugal

3. Department of Chemistry, University of Liverpool, Liverpool L69 7ZD, United Kingdom

Funder

Funda??o para a Ci?ncia e a Tecnologia

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c05307

Reference163 articles.

1. Tuberculosis

2. WHO. Global Tuberculosis Report, 2021.

3. Tuberculosis drug discovery in the post‐post‐genomic era

4. Advances in the development of new tuberculosis drugs and treatment regimens

5. New Era of TB Drug Discovery and Its Impact on Disease Management

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents;ACS Infectious Diseases;2024-08-16

2. A Rational Approach To Antitubercular Drug Design: Molecular Docking, Prediction of ADME Properties and Evaluation of Antitubercular Activity of Novel Isonicotinamide Scaffold;Recent Advances in Anti-Infective Drug Discovery;2024-08

3. A Review of Antibacterial Candidates with New Modes of Action;ACS Infectious Diseases;2024-07-17

4. Recent advances in the development of DprE1 inhibitors using AI/CADD approaches;Drug Discovery Today;2024-06

5. Design, 3D-QSAR, molecular docking, ADMET, molecular dynamics and MM-PBSA simulations for new anti-breast cancer agents;Chemical Physics Impact;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3